期刊文献+

腹腔镜下病灶切除、^(125)I粒子植入的复发妇科恶性肿瘤患者血清CA125水平变化及意义 被引量:2

Change and significance of serum CA125 level after implantation of ^(125)I seeds guided by laparoscopy in patients with recurrent gynecologic malignancies
下载PDF
导出
摘要 目的观察腹腔镜下病灶切除及125I粒子植入复发妇科恶性肿瘤患者血清CA125水平的变化,并探讨其意义。方法复发妇科恶性肿瘤患者30例,15例行腹腔镜下病灶切除并植入125I粒子(植入组),15例行开腹手术病灶切除(对照组)。放免法检测30例患者的血清CA125。结果术后1个月植入组血清CA125水平升高、对照组降低(P<0.05);术后3个月植入组中有9例血清CA125水平正常,而对照组中只有3例正常(P<0.05);术后3个月两组血清CA125下降至正常的患者其2 a无瘤生存率为83.3%(10/12),高于术后3个月CA125未降至正常者的50.0%(9/18),两者相比,P<0.05。结论腹腔镜下切除病灶并植入125I粒子的复发妇科恶性肿瘤患者术后血清CA125水平有短暂升高,术后3个月降至正常,可作为疗效及预后判断的有效指标。 Objective To study the CA125 level and its significance after laparoscopic resection and ^125I seeds inplantation in patients with recurrent gynecologic malignancies.Methods 30 cases with recurrent gynecologic malignancies were divided for average into two groups,15 cases of ^125I implantation group were deal with laparoscopic resection and 125I seeds inplantation,15 cases of control group were deal with laparotomy.Serum CA125 levels of 30 cases were measured by RIA.Results Serum CA125 level of ^125I implantation group were all increased in the first month after operation with which in control group dropped obviously(P〈0.05).CA125 level of 9 cases in ^125I implantation group and only 3 cases in control group dropped to normal in the third month after operation(P〈0.05).The 2 year tumor-free survival rate(83.3%) of the patients with normal CA125 level in the third month after operation was higher than those(50.0%) with abnormal CA125 level(P〈0.05).Conclusion There is temporary increased CA125 elevation after laparoscopic resection and 125I seeds implantation.CA125 level in the third month after operation is an effective marker for prognosis.
出处 《山东医药》 CAS 北大核心 2010年第26期8-9,共2页 Shandong Medical Journal
基金 海南省自然科学基金资助项目(80458)
关键词 妇科肿瘤 碘粒子 糖链抗原125 gynecologic neoplasms iodine seeds carbohydrate antigen-125
  • 相关文献

参考文献8

  • 1朱根海,杨舒盈,李诗运,贺国丽,陈春英,王雁.腹腔镜引导下^(125)I粒子植入治疗复发性妇科恶性肿瘤的临床观察[J].中华肿瘤防治杂志,2007,14(21):1656-1657. 被引量:5
  • 2Davelaar EM,van de Lande J,von Mensdorff-Pouilly S,et al.A combination of serum tumor markers identifies high-risk patients with early-stage squamous cervical cancer[J].Tumour Biol,2008,29(1):9-17.
  • 3Yu B,Xu PZ,Wang QW,et al.Clinical value of tumour specific growth factor (TSGF) and carbohydrate antigen-125 (CA125) in carcinoma of the endometrium[J].J Int Med Res,2009,37(3):878-883.
  • 4陈春英,杨舒盈,朱根海.CA_(125)水平动态监测预测卵巢上皮癌复发的价值[J].现代预防医学,2008,35(16):3080-3081. 被引量:2
  • 5周慧梅,黄惠芳,潘凌亚,沈铿,吴鸣,杨佳欣,郎景和.血清CA125值的变化对判断上皮性卵巢癌疗效及预后的临床研究[J].中国实用妇科与产科杂志,2008,24(3):204-206. 被引量:35
  • 6Riedinger JM,Bonnetain F,Basuyau JP,et al.Change in CA125 levels after the first cycle of induction chemotherapy is an independent predictor of epithelial ovarian tumor outcome[J].Ann Oncol,2007,18(5):881-885.
  • 7Zivanovic O,Sima CS,Iasonos A,et al.Exploratory analysis of serum CA125 response to surgery and the risk of relapse in patients with FIGO stage Ⅲc ovarian cancer[J].Gynecol Oncol,2009,115(2):209-214.
  • 8Mahner S,Woelber L,Jung S,et al.Prognostic significance of CA125 in the management of patients with recurrent epithelial ovarian carcinoma selected for secondary cytoreduction[J].Anticancer Res,2009,29(7):2817-2821.

二级参考文献19

  • 1张欣,吴令英.血清CA125在卵巢上皮癌治疗和预后中的作用[J].国外医学(肿瘤学分册),2005,32(3):218-221. 被引量:9
  • 2黄立,姚嘉斐.血清CA125检测对卵巢上皮性癌预后的价值[J].中国妇幼保健,2005,20(13):1566-1568. 被引量:6
  • 3李奇龙.腹腔镜手术治疗妇科恶性肿瘤的适应证与并发症[J].中华妇产科杂志,2005,40(7):499-501. 被引量:16
  • 4白静,王俊杰,修典荣,冉维强.术中超声引导放射性^(125)I粒子组织间植入治疗局部晚期胰腺癌[J].中国微创外科杂志,2006,6(5):356-358. 被引量:9
  • 5Ishiyama H, Kitano M, Satoh T, et al. Difference in rectal do simetry between pre-plan and post-implant analysis in transperineal interstitial brachytherapy for prostate cancer[J]. Radiother Oncol, 2006, 78(2):194-198.
  • 6Hilaris B S, Mastoras D A. Contemporary brachytherapy approaches in non-small-cell lung cancer[J]. J Surg Oncol, 1998, 69(4) :258 -- 264.
  • 7Sharma S K, Forgione H, Isaacs J H. Iodine-125 interstitial implants as salvage therapy for recurrent gynecologic malignancies [J]. Cancer, 1991, 67(10):2467-2471.
  • 8Monk B J, Tewari K S, Puthawala A A, et al. Treatment of recurrent gynecologic malignancies with iodine 125 permanent interstitial irradiation[J]. Int J Radiat Oncol Biol Phys, 2002, 52(3): 806--815.
  • 9Anglesio S, Calamia E, Fiandra C, et al. Prostate brachytherapy with iodine-125 seeds: radiation protection issues[J].Tumori, 2005, 91(4):335--338.
  • 10Berek JS, Bast RC. Ovarian cancer screening. The use of serial complementary tumor markers to improve sensitivity and specificity for early detection [ J ]. Cancer, 1995,76 ( Suppl 10 ) : 2092- 2096.

共引文献39

同被引文献10

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部